Clinical trials. Halt of Celebrex study threatens drug's future, other trials.
Couzin
Jennifer
J
D000544:Alzheimer Disease / Q000517:prevention & control; D000068579:Celecoxib; D002986:Clinical Trials as Topic; D003111:Colonic Polyps / Q000188:drug therapy / Q000517:prevention & control; D016861:Cyclooxygenase Inhibitors / Q000009:adverse effects* / Q000627:therapeutic use*; D004345:Drug Industry; D006801:Humans; D009203:Myocardial Infarction / Q000139:chemically induced; D009316:National Institutes of Health (U.S.); D011720:Pyrazoles / Q000009:adverse effects* / Q000627:therapeutic use*; D020521:Stroke / Q000139:chemically induced; D013449:Sulfonamides / Q000009:adverse effects* / Q000627:therapeutic use*; D014481:United States
D016861:Cyclooxygenase Inhibitors; D011720:Pyrazoles; D013449:Sulfonamides; D000068579:Celecoxib